Stocks
Allogene Therapeutics (ALLO) P/E US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| P/E | ? | -14.2 | -13.0 | -8.28 | -2.73 | -1.54 | -1.73 | ||
| Changes by years, y/y, % | +286% | -9% | -36% | -67% | -44% | -16.0% | |||
Allogene Therapeutics. P/E
Allogene Therapeutics. P/E, changes, %
Allogene Therapeutics (ALLO) P/E US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| P/E | ? | -2.05 | -2.07 | -1.61 | -1.67 | -2.61 | -1.73 | |
| Changes by years, y/y, % | -52% | -61% | -68% | -39% | +27% | |||
| Changes by quarters, q/q, % | -25% | +1% | -23% | +4% | +56% | |||
